Comprehensive molecular analysis of 333 primary prostate carcinomas
Seven subtypes defined by ETS fusions or mutations in
Substantial epigenetic heterogeneity, including a hypermethylated
Presumed actionable lesions in the PI3K, MAPK, and DNA repair pathways